Filings for Rule Number 4123-6-21.7

Title Reimbursement of opioids in the treatment of pain for a work related injury or occupational disease.
Agency Bureau of Workers' Compensation
Division
Contact Aniko Nagy
Phone 614-466-3293

Actions

Public Notice
RSFA Analysis
Rule
Appendices
Hearing Summary Reports
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum
    of Response
Title File Date Action Type Class Hearing Eff Date Exp Date FYR Documents
No Current Actions
Title File Date Action Type Class Hearing Eff Date Exp Date FYR Documents
Utilization of opioids in the subacute or chronic phases of pain treatment for a work-related injury or occupational disease. 08/07/2020 Final File Rescission 119.03 09/01/2020 Y
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Reimbursement of opioids in the treatment of pain for a work related injury or occupational disease. 08/07/2020 Final File New 119.03 09/01/2020 N
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Utilization of opioids in the subacute or chronic phases of pain treatment for a work-related injury or occupational disease. 05/29/2020 Original File Rescission 119.03 07/01/2020 Y
Public Notice
RSFA Analysis
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Reimbursement of opioids in the treatment of pain for a work related injury or occupational disease. 05/29/2020 Original File New 119.03 07/01/2020 N
Public Notice
RSFA Analysis
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Utilization of opioids in the subacute or chronic phases of pain treatment for a work-related injury or occupational disease. 09/19/2016 Final File New 119.03 10/01/2016 N
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Utilization of opioids in the subacute or chronic phases of pain treatment for a work-related injury or occupational disease. 07/13/2016 Original File New 119.03 08/18/2016 N
Public Notice
RSFA Analysis
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Public Notice
RSFA Analysis
Rule
Appendices
Hearing Summary Reports
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum
    of Response
Title File Date Action Type Class Hearing Eff Date Exp Date FYR
Public Notice
RSFA Analysis
Rule
Appendices
Hearing Summary Reports
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum
    of Response
Title File Date Action Type Class Hearing Eff Date Exp Date FYR
Utilization of opioids in the subacute or chronic phases of pain treatment for a work-related injury or occupational disease. 08/07/2020 Final File Rescission 119.03 09/01/2020 Y
Reimbursement of opioids in the treatment of pain for a work related injury or occupational disease. 08/07/2020 Final File New 119.03 09/01/2020 N
Utilization of opioids in the subacute or chronic phases of pain treatment for a work-related injury or occupational disease. 05/29/2020 Original File Rescission 119.03 07/01/2020 Y
Reimbursement of opioids in the treatment of pain for a work related injury or occupational disease. 05/29/2020 Original File New 119.03 07/01/2020 N
Utilization of opioids in the subacute or chronic phases of pain treatment for a work-related injury or occupational disease. 09/19/2016 Final File New 119.03 10/01/2016 N
Utilization of opioids in the subacute or chronic phases of pain treatment for a work-related injury or occupational disease. 07/13/2016 Original File New 119.03 08/18/2016 N